CLU and cancer: Consistent findings across diverse cell types, including cancer cells [11,23], retinal pigment epithelial cells [11], hepatocellular carcinoma cell lines [52], and endothelial tumor cells [49], emphasize the role of histone hyperacetylation induced by histone deacetylase inhibition in promoting CLU expression.